|HLA and pharmacogenetics of drug hypersensitivity|
R Pavlos, S Mallal, E Phillips
Pharmacogenomics 13 (11), 1285-1306, 2012
|Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF‐κB ligand|
J Xu, JW Tan, L Huang, XH Gao, R Laird, D Liu, S Wysocki, MH Zheng
Journal of Bone and Mineral Research 15 (11), 2178-2186, 2000
|Improving the effectiveness of penicillin allergy de-labeling|
J Bourke, R Pavlos, I James, E Phillips
The Journal of Allergy and Clinical Immunology: In Practice 3 (3), 365-374. e1, 2015
|SJS/TEN 2017: building multidisciplinary networks to drive science and translation|
KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018
|T cell–mediated hypersensitivity reactions to drugs|
R Pavlos, S Mallal, D Ostrov, S Buus, I Metushi, B Peters, E Phillips
Annual review of medicine 66, 439, 2015
|Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy|
R Pavlos, S Mallal, D Ostrov, Y Pompeu, E Phillips
The Journal of Allergy and Clinical Immunology: In Practice 2 (1), 21-33, 2014
|HLA-A* 32: 01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms|
KC Konvinse, JA Trubiano, R Pavlos, I James, CM Shaffer, CA Bejan, ...
Journal of allergy and clinical immunology 144 (1), 183-192, 2019
|HLAs: key regulators of T‐cell‐mediated drug hypersensitivity|
AJ Redwood, RK Pavlos, KD White, EJ Phillips
Hla 91 (1), 3-16, 2018
|Abacavir-reactive memory T cells are present in drug naive individuals|
A Lucas, M Lucas, A Strhyn, NM Keane, E McKinnon, R Pavlos, ...
PloS one 10 (2), e0117160, 2015
|A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis|
AW Beham, K Puellmann, R Laird, T Fuchs, R Streich, C Breysach, ...
PLoS pathogens 7 (11), e1002375, 2011
|Associations between HLA-DRB1* 0102, HLA-B* 5801 and hepatotoxicity during initiation of Nevirapine-containing regimens in South Africa|
E Phillips, JA Bartlett, I Sanne, MM Lederman, J Hinkle, F Rousseau, ...
Journal of acquired immune deficiency syndromes (1999) 62 (2), e55, 2013
|HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity|
NM Keane, RK Pavlos, E McKinnon, A Lucas, C Rive, CC Blyth, D Dunn, ...
Aids 28 (13), 1891-1901, 2014
|Pharmacogenomics of off‐target adverse drug reactions|
SL Garon, RK Pavlos, KD White, NJ Brown, CA Stone Jr, EJ Phillips
British journal of clinical pharmacology 83 (9), 1896-1911, 2017
|Individualization of antiretroviral therapy|
R Pavlos, EJ Phillips
Pharmacogenomics and personalized medicine 5, 1, 2012
|The combined utility of ex vivo IFN-γ release enzyme-linked immunospot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions|
JA Trubiano, K Strautins, AJ Redwood, R Pavlos, KC Konvinse, AK Aung, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (4), 1287-1296. e1, 2018
|Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles|
R Pavlos, EJ McKinnon, DA Ostrov, B Peters, S Buus, D Koelle, A Chopra, ...
Scientific reports 7 (1), 1-12, 2017
|High‐avidity, high‐IFNγ‐producing CD8 T‐cell responses following immune selection during HIV‐1 infection|
NM Keane, SG Roberts, CAM Almeida, T Krishnan, A Chopra, E Demaine, ...
Immunology and cell biology 90 (2), 224-234, 2012
|Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions|
JH Karnes, MA Miller, KD White, KC Konvinse, RK Pavlos, AJ Redwood, ...
Annual review of pharmacology and toxicology 59, 463-486, 2019
|Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses|
CAM Almeida, SG Roberts, R Laird, E McKinnon, I Ahmed, K Pfafferott, ...
Journal of immunological methods 344 (1), 2009
|Severe delayed drug reactions: role of genetics and viral infections|
R Pavlos, KD White, C Wanjalla, SA Mallal, EJ Phillips
Immunology and Allergy Clinics 37 (4), 785-815, 2017